Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/614077ab-88bb-482e-a85f-d131644972a8/

IDYA

Ideaya Biosciences Inc
Chart
$28.29
Latest Week 2026-06-05
HealthcareBiotechnologyMID
Snapshot 2026-06-07 · 0.0w · Fresh
0.54
OS Score
50.0%
Value
49.0%
Quality
50.0%
Momentum
4/9
F-Score
0.495
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
1 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
12-1 30%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
50.0%ile
P/S
11.1×
P/B
2.7×
FCF Yield
-0.036
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
50.00000000
/100 — 1=cheapest
VC2 (Trending Value)
50.00000000
/100
VC3 (Buyback)
50.00000000
/100
Negative FCF yield (-3.6%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
49.0%ile
ROE
-0.149
ROA
-0.136
Net Margin
-0.622
Op Margin
-0.814
GPA
0.216
D/E
0.10
Current
10.74
F-Score
4/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Stability
1.347
lower=better
Accruals
-0.053
lower=better
5yr Consist
No
Conservative balance sheet with D/E of 0.10.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
50.0%ile
6M Return
-21.1%
12M Return
30.2%
12-1 Mom
30.3%
Risk-Adj
0.73
Vol 252d
41.8%
Vol 60d
90.4%
↑ Expanding
Max DD 12M
-24.6%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 30% is very strong — a clear uptrend. Near-term vol (90%) is expanding vs long-term (42%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.54
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
31.5%
Sector Quality %ile
30.9%
P/B z-score
-0.19
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
PBYI Puma Biotechnology Inc 97.0% 80.0% 97.0% 92.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
Factor Interactions
Volatility Expanding
60-day vol (90%) significantly exceeds 252-day (42%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
27.1% avg (4 factors)
Quality
D
40.2% avg (8 factors)
Momentum
C
48.8% avg (4 factors)
Risk
C
47.1% avg (1 factors)
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.540—0—
Value %ile0.500—0—
Quality %ile0.490—0—
Momentum %ile0.500—0—
F-Score4.000—1—
Confidence0.848—1—
Volatility0.418—1—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Sales
11.14
Price / Book
2.68
FCF Yield
-3.6%
Sales Yield (1/P·S)
0.0958
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-14.9%
Return on Assets
-13.6%
Net Margin
-62.2%
Operating Margin
-81.4%
Gross Profit / Assets
Novy-Marx GPA
21.6%
Debt / Equity
0.10
Current Ratio
10.74
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.053
MomentumPrice trend strength over different horizons
6M Return
-21.1%
12M Return
30.2%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
30.3%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.73
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Earnings Stability (CV)
Lower = more stable
1.347
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
4
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
50
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
50
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
50
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity